𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease

✍ Scribed by Kobylecki, Christopher; Burn, David J.; Kass-Iliyya, Lewis; Kellett, Mark W.; Crossman, Alan R.; Silverdale, Monty A.

Book ID
121495630
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
200 KB
Volume
20
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levodopa-induced ocular dyskinesias in P
Levodopa-induced ocular dyskinesias in Parkinson's disease
✍ Gurutz Linazasoro; Nadege Van Blercom; Asier Lasa; Begoña Indakoetxea; Javier Ru 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

## Abstract Levodopa‐induced ocular dyskinesias are very uncommon. Usually they occur simultaneously with limb peak‐dose choreatic dyskinesias. We report on a patient with leftward and upward deviations of gaze during the peak effect of levodopa, and hypothesize that a severe dopaminergic denervati

Topiramate reduces levodopa-induced dysk
Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease
✍ Monty A. Silverdale; S.L. Nicholson; A.R. Crossman; J.M. Brotchie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract Overactive AMPA receptor‐mediated transmission may be involved in the pathogenesis of levodopa‐induced dyskinesia. The mechanism of action of the anticonvulsant drug topiramate involves attenuation of AMPA receptor‐mediated transmission. In this study, the potential antidyskinetic actio